Should I buy BXP, Inc. (BXP) stock or is it too late?
⭐ The most reliable of them, either direction: Citigroup — 66% of its targets hit on this sector (194 calls tested). It aims for $69 (-1.4 %), call made on August 5, 2026, maturing on August 5, 2027 (23 d ago).
Firm-by-firm track record on BXP, Inc.
| Firm | % right | Gain vs sector | Calls | Aims for |
|---|---|---|---|---|
| JP Morgan | 60 % | +12.6 % | 10 | $87 +24% |
| Argus Research | 75 % | +6.1 % | 8 | $70 +0% |
| Barclays | 63 % | +1.8 % | 19 | $79 +13% |
| Citigroup | 20 % | -0.6 % | 5 | $69 -1% |
| Evercore ISI Group | 42 % | -4.3 % | 12 | $68 -3% |
| Wells Fargo | 36 % | -5.7 % | 11 | $77 +10% |
| Mizuho | 25 % | -7.5 % | 8 | $68 -3% |
| Piper Sandler | 29 % | -9.3 % | 7 | $86 +23% |
✅ Reasons to believe
- The most reliable firm on BXP, Goldman Sachs (75% hit rate, 4 scored calls), targets $76 (call made on September 11, 2025, maturing on September 11, 2026) (+9%) in its most recent call.
- Pays a dividend (4.1% yield) — regular income on top of potential upside.
⚠️ Reasons to hesitate
- The consensus is not unanimous: of 12 ratings, 5 are neutral.
- Limited upside: the median target is only +4% from the current price.
- High valuation (P/E ~38): strong growth is already "priced in", leaving little room for error.
- A 12-month target is not a guaranteed path: the price can fall in the meantime.
The analyst consensus on BXP
Median target $73 (+4%) · 12 ratings · Buy consensus
⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.
Frequently asked questions
Should you invest in BXP, Inc. now?
We won't decide for you. The facts: 58% of analysts rate it a buy, median target $73 (+4%), and Goldman Sachs (most reliable on BXP, 75%) targets $76. Weigh that against valuation (P/E ~38). This is not personalized advice.
Is it too late to invest in BXP, Inc.?
Not according to analysts: the median target ($73) is still +4% above the current price ($70) (most reliable on BXP: Goldman Sachs, 75%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.
Is BXP, Inc. still worth investing in?
It depends on the gap between the price ($70) and its estimated value: analysts target $73 on median (+4%), with 58% buys (most reliable on BXP: Goldman Sachs, 75%). Cross-check with their real reliability on BXP and the cautions above. Information, not advice.
What's the main risk in buying BXP?
The consensus is not unanimous: of 12 ratings, 5 are neutral.
→ Go deeper: the full BXP, Inc. profile (consensus, analyst reliability, price target, performance).